Clinical Trial Update: Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of squalamine lactate for macular edema due to retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Squalamine lactate (squalamine lactate)

Snippet

Sponsor: Ohr Pharmaceutical Inc. | Conditions: Retinal Vein Occlusion, Macular Edema | Phase 1, Phase 2 | Status: COMPLETED